Sanjana Awasty
Endocrinology, Diabetes & Metabolism · Florence, KYNPI 1942760541
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in KY, where the typical reported total is $3,450.
Across 120 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$265
- Lilly USA, LLC$190
- Sequel Med Tech, LLC$184
- Regeneron Healthcare Solutions, Inc.$162
- Amgen$147
- Sanofi-aventis U.S. LLC$138
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,44099%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $265 |
| Lilly USA, LLC | 12 | $190 |
| Sequel Med Tech, LLC | 3 | $184 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| Amgen | 9 | $147 |
| Sanofi-aventis U.S. LLC | 7 | $138 |
| Corcept Therapeutics | 4 | $135 |
| Antares Pharma, Inc. | 7 | $130 |
| Ascendis Pharma Endocrinology Inc | 6 | $101 |
| Xeris Pharmaceuticals, Inc. | 5 | $89 |
| Novartis | 5 | $87 |
| Neurocrine Biosciences, Inc. | 3 | $86 |
| Radius Health, Inc. | 4 | $70 |
| AstraZeneca | 3 | $65 |
| Boehringer Ingelheim | 3 | $57 |
| Tandem Diabetes Care, Inc. | 1 | $47 |
| Averitas Pharma Inc. | 2 | $46 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Recordati_rare_diseases_inc. | 2 | $46 |
| BETA Bionics, Inc. | 1 | $40 |
| Cequr Corporation | 2 | $37 |
| Insulet Corporation | 1 | $34 |
| Astellas Pharma US Inc | 1 | $28 |
| Medtronic | 2 | $28 |
| Almatica Pharma LLC | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Mannkind Corporation | 1 | $22 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Soleno Therapeutics, Inc. | 1 | $19 |
| Avvisto Therapeutics, LLC | 1 | $19 |
| AbbVie | 1 | $17 |
| Tolmar, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TWIIST$139
How this compares
$2,459 in reported general payments places this provider in the 35th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.
See all endocrinology, diabetes & metabolism providers in Kentucky →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 16 | $170 |
| Methimazole | 16 | $96 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Florence
- Bradley EilermanFlorence$1.3M
- Heather CornFlorence$13K
- Ann BeersFlorence$6K
- Malik Waseem AhmadFlorence$2K
- Sergio Chang FigueroaMadisonville$1.2M
- Hisham AlrefaiLouisville$720K
- Harold BaysLouisville$214K
- Jahangir CyrusLouisville$155K
- Yancey HolmesCovington$148K
- Moussa AlhajAshland$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.